Prosecution Insights
Last updated: August 14, 2026

Hem Pharma Inc.

4 pending office actions • 2 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days

Portfolio Summary

4
Total Pending OAs
2
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

4
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other4 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
25% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
25% of docket
2
Business / Other
50% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

40 h
Manual time on pending OAs
8 h
Time saved (low, 20%)
14 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
GOUGH, TIFFANY MAUREEN 1 31.4% +46.9%
STUBBS, JOHN THOMAS 1
RAPILLO, KRISTINE K 1 28.8% +27.4%
SCHULTZHAUS, JANNA NICOLE 1 35.6% +36.2%

Hard Cases (4)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
17793855 METHOD AND SERVER FOR PROVIDING INTESTINAL MICROBIOME ANALYSIS RESULT RAPILLO, KRISTINE K 46d overdue
17793836 METHOD AND DEVICE FOR PROVIDING CUSTOMIZED SOLUTION FOR IMPROVING INTESTINAL ENVIRONMENT SCHULTZHAUS, JANNA NICOLE 5d overdue
18919581 NOVEL BIFIDOBACTERIUM BIFIDUM HEM972 STRAIN, AND COMPOSITION FOR IMPROVING INTESTINAL ENVIRONMENT, COMPRISING SAME STRAIN OR CULTURE OF SAME GOUGH, TIFFANY MAUREEN
18181387 METHOD AND APPARATUS FOR DIAGNOSING COLON PLYP USING MACHINE LEARNING MODEL STUBBS, JOHN THOMAS

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
17793855 METHOD AND SERVER FOR PROVIDING INTESTINAL MICROBIOME ANALYSIS RESULT RAPILLO, KRISTINE K 46d overdue
17793836 METHOD AND DEVICE FOR PROVIDING CUSTOMIZED SOLUTION FOR IMPROVING INTESTINAL ENVIRONMENT SCHULTZHAUS, JANNA NICOLE 5d overdue
18919581 NOVEL BIFIDOBACTERIUM BIFIDUM HEM972 STRAIN, AND COMPOSITION FOR IMPROVING INTESTINAL ENVIRONMENT, COMPRISING SAME STRAIN OR CULTURE OF SAME GOUGH, TIFFANY MAUREEN

Top Art Units

Art UnitApps
3682 1
1685 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18919581 NOVEL BIFIDOBACTERIUM BIFIDUM HEM972 STRAIN, AND COMPOSITION FOR IMPROVING INTESTINAL ENVIRONMENT, COMPRISING SAME STRAIN OR CULTURE OF SAME GOUGH, TIFFANY MAUREEN §101§112 Non-Final OA Pending Oct 18, 2024
18181387 METHOD AND APPARATUS FOR DIAGNOSING COLON PLYP USING MACHINE LEARNING MODEL STUBBS, JOHN THOMAS §101§102§103 Non-Final OA Pending Mar 09, 2023
17793855 METHOD AND SERVER FOR PROVIDING INTESTINAL MICROBIOME ANALYSIS RESULT RAPILLO, KRISTINE K 3682 §101§103 Final Rejection 46d overdue Pending Dec 08, 2022
17793836 METHOD AND DEVICE FOR PROVIDING CUSTOMIZED SOLUTION FOR IMPROVING INTESTINAL ENVIRONMENT SCHULTZHAUS, JANNA NICOLE 1685 §101§112 Final Rejection 5d overdue Pending Jul 19, 2022

Managing Hem Pharma Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month